Login

JOHNSON JOHN 4 SEC Filings

Filed On Filing
26 Jun 2026 Form 4: Johnson John, Director · AxoGen, Inc.

Granted 4,392 Restricted Stock Units

23 Jun 2026 Form 4: Johnson John, Director · AxoGen, Inc.

Received 14,150 shares by exercise or conversion · Acquired 14,150 Restricted Stock Units (Option Exercise/Conversion)

05 Jun 2026 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Sold 15,000 shares ($91.4K) · Received 24,193 shares as a grant or award · Granted 32,996 Stock Option (Right to Buy) ($203K)

26 May 2026 Form 4: Johnson John, Director · Verastem Inc

Received 36,000 shares as a grant or award

08 May 2026 Form 4: Johnson John, Director · AxoGen, Inc.

Received 11,050 shares by exercise or conversion ($77.8K) · Sold 11,050 shares ($478K)

19 Dec 2025 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Sold 135,400 shares ($977K)

10 Dec 2025 Form 4: Johnson John, Director · AxoGen, Inc.

Sold 23,693 shares ($740K) · Received 11,891 shares by exercise or conversion ($74.9K) · Received 8,545 shares by exercise or conversion ($53.8K) · 1 more

15 Aug 2025 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Sold 107,500 shares ($786K)

20 Jun 2025 Form 4: Johnson John, Director · AxoGen, Inc.

Granted 14,150 Restricted Stock Units

11 Jun 2025 Form 4: Johnson John, Director · AxoGen, Inc.

Sold 4,073 shares ($43.2K)

04 Jun 2025 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Received 50,000 shares as a grant or award

27 May 2025 Form 4: Johnson John, Director · Verastem Inc

Received 8,333 shares as a grant or award · Granted 12,500 Stock Option (right to buy)

20 Dec 2024 Form 4: Johnson John, Director · Applied Therapeutics, Inc.

Received 500,000 shares as a grant or award · Granted 1,000,000 Stock Option (Right to Buy)

04 Sep 2024 Form 4: Johnson John, Director · AxoGen, Inc.

Received 11,904 shares by exercise or conversion

20 Jun 2024 Form 4: Johnson John, Director · Verastem Inc

Received 8,333 shares as a grant or award · Granted 12,500 Stock Option (right to buy)

10 Jun 2024 Form 4: Johnson John, Director · AxoGen, Inc.

Received 10,653 shares as a grant or award · Granted 18,248 Employee Stock Option (right to purchase)

05 Jun 2024 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Received 50,000 shares as a grant or award

01 Apr 2024 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Acquired 89,571 shares (Other Transaction)

18 Mar 2024 Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc.

Received 215,600 shares by exercise or conversion ($429K)

13 Mar 2024 Form 4: Johnson John, Director · Verastem Inc

Disposed of 8,549 Stock Option (right to buy) (Disposition to Issuer) · Granted 8,549 Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support